Literature DB >> 24893580

Lack of association between TESPA1 gene polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and ankylosing spondylitis in a Chinese population.

Si Liu1, Li Liu, Shanshan Wu, Ting Yang, Faming Pan, Laura Laslett, Guo Xia, Yanting Hu, Dazhi Fan, Ning Ding, Shengqian Xu, Guoqi Cai, Li Wang, Lihong Xin.   

Abstract

We investigated whether TESPA1 gene polymorphisms were associated with increased risk of developing ankylosing spondylitis (AS). We also studied whether TESPA1 gene interacts with environmental factors. A total of 494 patients with AS and 478 matched healthy controls were genotyped for four SNPs (rs1801876, rs2171497, rs4758994, and rs997173) in the TESPA1 gene. We found no evidence of association between these SNPs and AS susceptibility, and between their haplotypes and the disease. But, patients with rs1801876 GA, GG, and AA genotypes had significantly different Bath Ankylosing Spondylitis Functional Index (BASFI) scores (p = 0.023). There were significantly different visual analogue scale (VAS) night pain assessment scores (p = 0.040) and BASFI scores (p = 0.023) among different genotypes at rs2171497 locus. There were also significantly different chest expansion scores (p = 0.042) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores (p = 0.014) among different genotypes at rs997173 locus. For multiple testing, Bonferroni correction was performed. After Bonferroni correction, clinical characteristics of these three loci showed association between different genotype groups. These findings indicated that the TESPA1 gene is not involved in AS genetic predisposition in the Han Chinese population; however, it may play an important role in the clinical characteristics of AS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24893580     DOI: 10.1007/s10753-014-9936-8

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

Review 1.  Regulatory T cells and mechanisms of immune system control.

Authors:  Anne O'Garra; Paulo Vieira
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

2.  Tespa1: another gatekeeper for positive selection.

Authors:  Nicholas R J Gascoigne; Guo Fu
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

3.  Tespa1 protein is phosphorylated in response to store-operated calcium entry.

Authors:  Takahiro Fujimoto; Hiroshi Matsuzaki; Masatoshi Tanaka; Senji Shirasawa
Journal:  Biochem Biophys Res Commun       Date:  2013-03-26       Impact factor: 3.575

Review 4.  Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.

Authors:  Sachiko Miyake; Takashi Yamamura
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-09

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls.

Authors:  L Zhang; L B Jarvis; H-J Baek; J S Hill Gaston
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

7.  Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling.

Authors:  Di Wang; Mingzhu Zheng; Lei Lei; Jian Ji; Yunliang Yao; Yuanjun Qiu; Lie Ma; Jun Lou; Chuan Ouyang; Xue Zhang; Yuewei He; Jun Chi; Lie Wang; Ying Kuang; Jianli Wang; Xuetao Cao; Linrong Lu
Journal:  Nat Immunol       Date:  2012-05-06       Impact factor: 25.606

8.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Authors:  Adrian Cortes; Johanna Hadler; Jenny P Pointon; Philip C Robinson; Tugce Karaderi; Paul Leo; Katie Cremin; Karena Pryce; Jessica Harris; Seunghun Lee; Kyung Bin Joo; Seung-Cheol Shim; Michael Weisman; Michael Ward; Xiaodong Zhou; Henri-Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Lei Jiang; Yu Liu; Xin Wu; Linda A Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; Louise Appleton; Claire Farrah; Jonathan Lau; Tony J Kenna; Nigil Haroon; Manuel A Ferreira; Jian Yang; Juan Mulero; Jose Luis Fernandez-Sueiro; Miguel A Gonzalez-Gay; Carlos Lopez-Larrea; Panos Deloukas; Peter Donnelly; Paul Bowness; Karl Gafney; Hill Gaston; Dafna D Gladman; Proton Rahman; Walter P Maksymowych; Huji Xu; J Bart A Crusius; Irene E van der Horst-Bruinsma; Chung-Tei Chou; Raphael Valle-Oñate; Consuelo Romero-Sánchez; Inger Myrnes Hansen; Fernando M Pimentel-Santos; Robert D Inman; Vibeke Videm; Javier Martin; Maxime Breban; John D Reveille; David M Evans; Tae-Hwan Kim; Bryan Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2013-06-09       Impact factor: 38.330

9.  Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  Lei Zhang; Yong-gang Li; Yu-hua Li; Lei Qi; Xin-guang Liu; Cun-zhong Yuan; Nai-wen Hu; Dao-xin Ma; Zhen-feng Li; Qiang Yang; Wei Li; Jian-min Li
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

10.  Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.

Authors:  Erin E Hillhouse; Jean-Sébastien Delisle; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

View more
  1 in total

1.  Tespa1 is associated with susceptibility but not severity of rheumatoid arthritis in the Zhejiang Han population in China.

Authors:  Yunliang Yao; Hui Zhang; Shengwen Shao; Ge Cui; Ting Zhang; Hui Sun
Journal:  Clin Rheumatol       Date:  2015-03-04       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.